Skip to main navigation Skip to search Skip to main content

A randomized, double-blind, active-controlled, multicenter, 52-week study to evaluate the safety and efficacy of an LCZ696 regimen on arterial stiffness through assessment of central blood pressure in elderly patients with essential

Project: Research

Project Details

StatusFinished
Effective start/end date11/1/1205/31/16

Funding

  • Novartis Pharmaceuticals Corporation: $170,714.40